tbuckley/cabot-search huggingface dataset:
Abstract 3438: Comparison of Endothelial Progenitor Cell Capture Stent with Bare Metal Stent In Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction
Authors: Tay Lik-Wui Edgar, Chua Melissa-Co, Lee Chi-Hang, Low Adrian, Lim Jimmy, Lim Ing-Haan, Teo Swee-Guan, Tan Huay Cheem
Journal: Circulation (2007)

Background: The endothelial progenitor cell (EPC) capture bio-engineered stent (Genous ® stent, OrbusNeich) was designed to attract circulating EPCs and promote rapid endothelization. The aim of this study was to compare clinical outcomes between patients with ST-segment elevation myocardial infarction (STEMI) who received this stent versus those who received Liberte (Boston Scientific) bare metal stents. Methodology: Three hundred and forty two patients who presented to our centers with STEMI without cardiogenic shock and underwent primary PCI with either EPC Capture-or bare metal stent implantation were enrolled in this study. All patients received dual anti-platelet therapy for a month; and statin therapy was initiated soon after PCI. The study endpoints were major adverse cardiac events (MACE) at 30 days, 6 months and 1 year. Results: A total of 164 EPC Capture stents and 178 BMS were implanted. Baseline patient characteristics were comparable in the 2 groups. The mean lesion length in the 2 groups were 20.4.0 ± 5.1 and 22.8 ± 7.6mm, and the mean reference vessel diameter 3.14 ± 0.65 and 2.70 ± 1.14 mm respectively. At 6 months, the results were: Conclusion: There was no significant difference in MACE at 6 month between EPC Capture-and bare metal stents in patients with STEMI who underwent primary PCI. The 1-year data will be presented at the meeting.
Joseph Goldberger Fellowship Grants for Research in Clinical Nutrition
Journal: JAMA (1968)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
THE CASE OF MEDICAL INSPECTOR KERSHNER OF THE NAVY.
Journal: JAMA (1896)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Suggestions Concerning Publication of Association Papers.
Journal: JAMA (1898)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2024 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Mortality by Hispanic status in the United States
Authors: P. D. Sorlie
Journal: JAMA (1993)

<h3>Objective.</h3> —To compare all-cause and cause-specific mortality rates between Hispanic and non-Hispanic groups and estimate the effect of family income, place of birth, and place of residence on these rates. <h3>Design.</h3> —Cohort study using national survey data matched to the National Death Index, with a mortality follow-up period of 9 years. <h3>Setting.</h3> —The noninstitutionalized population of the United States. <h3>Participants.</h3> —Approximately 700000 respondents (aged 25 years or older), including 40 000 Hispanics, to national surveys conducted by the US Bureau of the Census (Current Population Surveys). <h3>Outcome Measures.</h3> —All causes and underlying cause of death, coded from the death certificate, occurring between 1979 and 1987. <h3>Results.</h3> —Adjusting for age, Hispanics were shown to have lower mortality from all causes compared with non-Hispanics (standardized rate ratio [SRR], 0.74 for men, 0.82 for women), lower mortality from cancer (SRR, 0.69 for men, 0.61 for women), lower mortality from cardiovascular disease (SRR, 0.65 for men, 0.80 for women), higher mortality from diabetes (SRR, 1.86 for men, 2.38 for women), and higher mortality from homicide (SRR, 3.60 for men). After adjusting for differences in annual family income, the relative mortality ratios were even lower for Hispanics than non-Hispanics. <h3>Conclusion.</h3> —These data describe, in a large national cohort study, a lower mortality in Hispanics than in non-Hispanics. This mortality is particularly low after adjustment for differences in family income. (<i>JAMA</i>. 1993;270:2464-2468)
Table of Contents
Authors: Marc Rothenberg, Harold Nelson, Tyra Bryant, Glorisa Canino, Elizabeth Mcquaid, Cynthia Rand, San Juan, Puerto Rico, Robert Valet, Tamara Perry, Tina Hartert, Little Rock, Atul Khasnis, Carol Langford, Andrea Apter, Adrian Casillas, La Esra Ozcan, Lilit Garibyan, Jhe-Yun Lee, Richard Bram, Kong-Peng Lam, Raif Geha, Sabine Ring, Stephen Oliver, Bruce Cronstein, Alexander Enk, Karsten Mahnke, Ruchi Gupta, Xingyou Zhang, Lisa Sharp, John Shannon, Kevin Weiss, Washington Hines, Leea Keski-Nisula, Marja-Leena Katila, Sami Remes, Seppo Heinonen, Juha Pekkanen, Salome Scholtens, Alet Wijga, Jacob Seidell, Bert Brunekreef, Johan De Jongste, Ulrike Gehring, Dirkje Postma, Marjan Kerkhof, Henriette Smit, Richard Schwartzstein, Diane Gold, Salma Musaad, Tia Patterson, Mark Ericksen, Mark Lindsey, Kim Dietrich, Paul Succop, Gurjit Khurana Hershey, E Sutherland, Erik Lehman, Mihaela Teodorescu, Michael Wechsler, David Naimi, Tovia Do, Kenneth Freedman, Ed Ginsburg, Daniel Bogen, Fuad Baroody, Deanna Shenaq, Marcy Detineo, Jianghong Wang, Robert Naclerio, Philippe-Jean Bousquet, Christophe Combescure, Jean-Michel Klossek, Jean-Pierre Daure, Jean Bousquet, Hans Bisgaard, Liselotte Halkjaer, Rikke Hinge, Charlotte Giwercman, Colin Palmer, Lori Silveira, Matthew Strand, Jonathan Bernstein, Marjorie Morgan, Debajyoti Ghosh, Larry Arlian, Riccardo Asero, Alberto Tedeschi, Massimo Cugno, Paderno Dugnano, Martin Metz, Ana Gime ´nez-Arnau, Elena Borzova, Clive Grattan, Markus Magerl, Marcus Maurer, Madhu Narra, William Shearer, Tex Reply, Esra Ozcan, Luigi Notarangelo, Jerry Tam, Nicola Grant, Laura Freire-Moran, Helen Tolmie, Neil French, Stephen Gordon, Sheldon Cohen
Journal: Journal of Allergy and Clinical Immunology (2009)
Chronic Lymphocytic Leukemia Cells Impair Mitochondrial Fitness in CD8+ T Cells and Impede CAR T Cell Efficacy
Authors: Jaco A. C. Van Bruggen, Anne W. J. Martens, Joseph A Fraietta, Tom Hofland, Sanne Tonino, Eric Eldering, Mark-David Levin, Peter J. Siska, Sanne Endstra, Jeffrey C Rathmell, Carl H June, David L. Porter, J. Joseph Melenhorst, Gerritje J. W. van der Windt, Arnon P. Kater
Journal: Blood (2018)
Energy intake and weight gain of very low birthweight babies fed raw expressed breast milk.
Journal: BMJ (1982)

of correlation between energy intake and weight gain in preterm infants fed expressed breast milk.A further contributing factor, previously described by the Nottingham group and others,' 2 must also be considered- namely, the amount of fat which is lost in the process of milk being given to the baby.As part of a study investigating various effects of continuous and bolus intragastric milk feeding (unpublished data) we estimated the fat content of bank breast milk before and after transit down a feeding tube.An in vitro study simulating clinical practice was set up with rates varying from 4 to 10 ml/hour.The percentage of fat which was lost varied from 6 to 630,) (mean 26o0).Proportionally more was lost at slower rates (4 to 6 ml/hour).The fat loss during continuous feeding was con- siderably greater than that lost by bolus.Variable loss of human milk fat in feeding tubes can invalidate metabolic studies and must be taken into account when investigating the relation between weight gain and energy intake.It is also wasted effort to improve the fat content of human milk arriving at a milk bank and to spend much money and effort in its preparation if equal attention is not given to other factors which adversely affect the amount of fat reaching the baby.
New Developments and Changing Concepts In Cancer Chemotherapy
Journal: JNCI Journal of the National Cancer Institute (1978)

Journal Article New Developments and Changing Concepts In Cancer Chemotherapy Get access JNCI: Journal of the National Cancer Institute, Volume 61, Issue 1, July 1978, Page 269, https://doi.org/10.1093/jnci/61.1.269-a Published: 01 July 1978
This Issue At A Glance
Authors: Lori Baker Schena, John Kerrison
Journal: Ophthalmology (2006)

The potential to achieve a lower target intraocular pressure (IOP) with combined medical therapy in patients with primary open-angle glaucoma (POAG) prompted Webers et al (p. 40) to conduct a meta-analysis to estimate the IOP-lowering effect of 2% dorzolamide or 0.005% latanoprost when added to 0.5% timolol. After reviewing 17 articles, the investigators found that the addition of these 2 therapeutic agents further lowers IOP in eyes using timolol. In an attempt to extrapolate these results to clinical practice, the investigators chose only studies that included patients with POAG or ocular hypertension in at least 85% of cases.
Desensitization to Dapsone in HIV- Positive Patients
Authors: Neil J. Lewis
Journal: JAMA (1992)

<h3>To the Editor.</h3> —In a prospective randomized double-blind study reported by Medina et al<sup>1</sup>in<i>The New England Journal of Medicine</i>, dapsone in combination with trimethoprim was as effective as a combination of trimethoprim and sulfamethoxazole (TMP/ SMX) for<i>Pneumocystis carinii</i>pneumonia (PCP) treatment and significantly better tolerated (<i>P</i>=.025). Neutropenia and elevated transaminase levels were five times less frequent in the dapsone group, but cutaneous reactions and nausea and vomiting occurred in equal numbers of patients. For prophylaxis, we reported that oral dapsone (25 mg, four times daily) was equally effective as daily TMP/SMX in preventing PCP with adverse reactions in 10% of those receiving dapsone vs 38% of those receiving TMP/SMX.<sup>2</sup>These findings and the appearance of other reports of dapsone efficacy in PCP prophylaxis<sup>3,4</sup>prompted us to explore desensitization of patients with the acquired immunodeficiency syndrome (AIDS) demonstrating a clear sensitivity reaction to dapsone.
Late mortality after childhood acute lymphoblastic leukemia (ALL)
Authors: L. L. Robison, L. Francisco, P. Gaynon, H. Sather, M. Trigg, G. Reaman, W. A. Bleyer, W. Carroll, S. Bhatia
Journal: Journal of Clinical Oncology (2004)

8508 Background: Long-term outcomes of children with ALL treated on cooperative group trials need to be defined. Methods: We assessed late mortality [death occurring 5+ years (yrs) after diagnosis (dx)] in a retrospective cohort of 8,444 patients (pts), with childhood ALL, treated on Children's Oncology Group (COG) therapeutic protocols between 1979 and 1990. Vital status was determined using medical records, National Death Index, and Social Security Death Index. Age- and sex-standardized mortality ratios (SMR) were calculated using US population mortality data. Results: A total of 6,424 pts (56% males, 80% Caucasians) survived 5+ yrs. Median age at dx was 4.6 yrs, and 15.6 yrs at follow-up. 549 deaths occurred 5+ yrs from dx with primary disease, infection and hemorrhage accounting for 65%. Multivariate analysis revealed risk of relapse-related mortality to be lower in females (Relative Risk (RR)=0.8, p=0.03), dx at age 1 to 10 yrs (RR=0.5, p=0.02) and dx after 1985 (RR=0.6, p=0.01). Non-relapse-related mortality was lower among females (RR=0.7, p=0.02). The cohort was at a 7.5-fold increased risk of late death when compared with the general population (Table). Overall survival at 20 years was 91%, 99%, and 99.4% for 5+, 10+ and 15+ yr survivors, respectively. Therapeutic summaries were available for a subcohort of 2,929 5-yr survivors treated between 1983–1989. The overall survival was 91.5% at 15 yrs, and the subcohort was at a 7.8-fold risk of late death. Anthracyclines (>200 mg/m2: RR=0.6, p=0.07) and cyclophosphamide (>2000 mg/m2: RR=0.7, p=0.06) offered protection against 5+ yr relapse-related mortality. Anthracyclines did not increase the risk of deaths due to cardiac causes.Conclusions: At 15 yrs from dx, risk of late death is no longer elevated among ALL survivors. No significant financial relationships to disclose.
Describing readmissions to an Ebola case management centre (CMC), Sierra Leone, 2014
Authors: G Fitzpatrick, F Vogt, O B Moi Gbabai, B Black, M Santantonio, E Folkesson, T Decroo, M Van Herp
Journal: Eurosurveillance (2014)

Case management centres (CMCs) are part of the outbreak control plan for Ebola virus disease (EVD). A CMC in Sierra Leone had 33% (138/419) of primary admissions discharged as EVD negative (not a case). Fifteen of these were readmitted within 21 days, nine of which were EVD positive. All readmissions had contact with an Ebola case in the community in the previous 21 days indicating that the infection was likely acquired outside the CMC.
Clinical Manifestations and Therapy of Acute Lead Intoxication Due to the Ingestion of Illicitly Distilled Alcohol
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Malpractice
Authors: Jay A. Gold
Journal: JAMA (2005)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Monitoring genotoxic exposure in uranium mines
Authors: R J Srám, L Dobiás, P Rössner, D Veselá, D Veselý, R Rakusová, V Rericha
Journal: Environmental Health Perspectives (1993)

Recent data from deep uranium mines in Czechoslovakia indicated that miners are exposed to other mutagenic factors in addition to radon daughter products.Mycotoxins were identified as a possible source of mutagens in these mines.Mycotoxins were examined in 38 samples from mines and in throat swabs taken from 116 miners and 78 controls.The following mycotoxins were identified from mines samples: aflatoxins B1 and GI, citrinin, citreoviridin, mycophenolic acid, and sterigmatocystin.Some mold strains isolated from mines and throat swabs were investigated for mutagenic activity by the SOS chromotest and Salmonella assay with strains TA100 and TA98.Mutagenicity was observed, especially with metabolic activation in vitro.These data suggest that mycotoxins produced by molds in uranium mines are a new genotoxic factor for uranium miners.
Revascularization for femoropopliteal disease. A decision and cost-effectiveness analysis
Authors: M. G. Hunink
Journal: JAMA (1995)

<h3>Objective.</h3> —To evaluate the relative benefits and cost-effectiveness of revascularization for femoropopliteal disease using percutaneous transluminal angioplasty or bypass surgery. <h3>Design.</h3> —Decision analysis using a multistate transition simulation model (Markov process) and cost-effectiveness analysis from the perspective of the health care system. <h3>Setting.</h3> —Based on mortality, morbidity, patency, and cost data from a literature review. <h3>Patients.</h3> —Hypothetical cohort of patients with chronic femoropopliteal disease who desire revascularization. Subgroup analysis for patients defined by age, sex, indication, lesion type, and graft type. <h3>Interventions.</h3> —Percutaneous transluminal angioplasty, bypass surgery, and a strategies combining the two treatments. <h3>Main Outcome Measures.</h3> —Five-year patency results, quality-adjusted life expectancy, lifetime costs, and incremental cost-effectiveness ratios. <h3>Results.</h3> —For 65-year-old men with disabling claudication and a femoropopliteal stenosis or occlusion and for 65-year-old men with chronic critical ischemia and a femoropopliteal stenosis, initial angioplasty increased quality-adjusted life expectancy by 2 to 13 months and resulted in decreased lifetime expenditures compared with bypass surgery. For patients with chronic critical ischemia and a femoropopliteal occlusion, initial bypass surgery increased quality-adjusted life expectancy by 1 to 4 months and resulted in decreased lifetime expenditures compared with angioplasty. Sensitivity analysis demonstrated that angioplasty would always be the preferred initial treatment if the angioplasty 5-year patency rate exceeds 30%. <h3>Conclusion.</h3> —Angioplasty is the preferred initial treatment in patients with disabling claudication and a femoropopliteal stenosis or occlusion and in those with chronic critical ischemia and a stenosis. Bypass surgery is the preferred initial treatment in patients with chronic critical ischemia and a femoropopliteal occlusion. (<i>JAMA</i>. 1995;274:165-171)
Gastrointestinal disorders in runners
Authors: J. D. Cantwell
Journal: JAMA (1981)

<h3>To the Editor.—</h3> Gastrointestinal disturbances were recently described in two long-distance runners, one of whom had bloody diarrhea (1980; 243:1743). I wish to describe two additional instances of the latter and to caution that the entity may mimic acute appendicitis and Crohn's disease. <h3>Report of a Cases.—Case 1.—</h3> A 17-year-old man ran a competitive 1.6-km race in 4:23 despite feelings of fatigue for the previous two weeks. He rested a day and then did vigorous anaerobic training (20 sets of 180-m dashes, each under 30 s, with the exercise pulse rate of 210 beats per minute and the recovery rate of 170 to 180 beats per minute) in preparation for a state tournament competition. That evening he had transient crampy abdominal pain, gas, and light brown diarrhea. The next day he did three 0.8-km runs (2:10 each) and two 1.6-km runs (4:35 pace). Mild diarrhea was noted in
EASTERN COUNTIES DERMATOLOGICAL SOCIETY.
Journal: British Journal of Dermatology (1963)

British Journal of DermatologyVolume 75, Issue 7 p. 295-296 EASTERN COUNTIES DERMATOLOGICAL SOCIETY. First published: July 1963 https://doi.org/10.1111/j.1365-2133.1963.tb15689.xAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Volume75, Issue7July 1963Pages 295-296 RelatedInformation